163 related articles for article (PubMed ID: 16509027)
1. Impact of a piperacillin-tazobactam shortage on antimicrobial prescribing and the rate of vancomycin-resistant enterococci and Clostridium difficile infections.
Mendez MN; Gibbs L; Jacobs RA; McCulloch CE; Winston L; Guglielmo BJ
Pharmacotherapy; 2006 Jan; 26(1):61-7. PubMed ID: 16509027
[TBL] [Abstract][Full Text] [Related]
2. Shifts in antimicrobial consumption and infection rates before and during a piperacillin/tazobactam shortage.
King ST; Barber KE; Parham JJ; Stover KR
J Glob Antimicrob Resist; 2017 Dec; 11():111-113. PubMed ID: 28774865
[TBL] [Abstract][Full Text] [Related]
3. The Effect of a Piperacillin/Tazobactam Shortage on Antimicrobial Prescribing and Clostridium difficile Risk in 88 US Medical Centers.
Gross AE; Johannes RS; Gupta V; Tabak YP; Srinivasan A; Bleasdale SC
Clin Infect Dis; 2017 Aug; 65(4):613-618. PubMed ID: 28444166
[TBL] [Abstract][Full Text] [Related]
4. Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit.
May AK; Melton SM; McGwin G; Cross JM; Moser SA; Rue LW
Shock; 2000 Sep; 14(3):259-64. PubMed ID: 11028540
[TBL] [Abstract][Full Text] [Related]
5. Increase in the rate of nosocomial Clostridium difficile-associated diarrhoea during shortages of piperacillin-tazobactam and piperacillin.
Alston WK; Ahern JW
J Antimicrob Chemother; 2004 Mar; 53(3):549-50. PubMed ID: 14963072
[No Abstract] [Full Text] [Related]
6. Acquisition of rectal colonization by vancomycin-resistant Enterococcus among intensive care unit patients treated with piperacillin-tazobactam versus those receiving cefepime-containing antibiotic regimens.
Paterson DL; Muto CA; Ndirangu M; Linden PK; Potoski BA; Capitano B; Bonomo RA; Aron DC; Donskey CJ
Antimicrob Agents Chemother; 2008 Feb; 52(2):465-9. PubMed ID: 18025111
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of colonization and infection with methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus and of Clostridium difficile infection in Canadian hospitals.
Simor AE; Williams V; McGeer A; Raboud J; Larios O; Weiss K; Hirji Z; Laing F; Moore C; Gravel D;
Infect Control Hosp Epidemiol; 2013 Jul; 34(7):687-93. PubMed ID: 23739072
[TBL] [Abstract][Full Text] [Related]
8. Reduction in vancomycin-resistant Enterococcus and Clostridium difficile infections following change to tympanic thermometers.
Brooks S; Khan A; Stoica D; Griffith J; Friedeman L; Mukherji R; Hameed R; Schupf N
Infect Control Hosp Epidemiol; 1998 May; 19(5):333-6. PubMed ID: 9613694
[TBL] [Abstract][Full Text] [Related]
9. Lack of increased colonization with vancomycin-resistant enterococci during preferential use of vancomycin for treatment during an outbreak of healthcare-associated Clostridium difficile infection.
Miller M; Bernard L; Thompson M; Grima D; Pepin J
Infect Control Hosp Epidemiol; 2010 Jul; 31(7):710-5. PubMed ID: 20518636
[TBL] [Abstract][Full Text] [Related]
10. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci.
Quale J; Landman D; Saurina G; Atwood E; DiTore V; Patel K
Clin Infect Dis; 1996 Nov; 23(5):1020-5. PubMed ID: 8922796
[TBL] [Abstract][Full Text] [Related]
11. The unexpected benefits of the national piperacillin/tazobactam shortage on antibiotic stewardship.
Cunha BA
Infect Dis (Lond); 2016 Apr; 48(4):328-329. PubMed ID: 26592309
[No Abstract] [Full Text] [Related]
12. Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin.
Shin JW; Yong D; Kim MS; Chang KH; Lee K; Kim JM; Chong Y
J Infect Chemother; 2003 Mar; 9(1):62-7; discussion 104-5. PubMed ID: 12673410
[TBL] [Abstract][Full Text] [Related]
13. Effect of the increasing use of piperacillin/tazobactam on the incidence of vancomycin-resistant enterococci in four academic medical centers.
Stiefel U; Paterson DL; Pultz NJ; Gordon SM; Aron DC; Donskey CJ
Infect Control Hosp Epidemiol; 2004 May; 25(5):380-3. PubMed ID: 15188842
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of Antibiotic Resistance among Hospital- and Community-Acquired Toxigenic Clostridium difficile Isolates over 5-Year Period in Kuwait.
Jamal WY; Rotimi VO
PLoS One; 2016; 11(8):e0161411. PubMed ID: 27536994
[TBL] [Abstract][Full Text] [Related]
15. Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea.
Wilcox MH; Freeman J; Fawley W; MacKinlay S; Brown A; Donaldson K; Corrado O
J Antimicrob Chemother; 2004 Jul; 54(1):168-72. PubMed ID: 15163654
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile and vancomycin-resistant enterococcus: the new nosocomial alliance.
Poduval RD; Kamath RP; Corpuz M; Norkus EP; Pitchumoni CS
Am J Gastroenterol; 2000 Dec; 95(12):3513-5. PubMed ID: 11151886
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich.
Büchler AC; Rampini SK; Stelling S; Ledergerber B; Peter S; Schweiger A; Ruef C; Zbinden R; Speck RF
BMC Infect Dis; 2014 Nov; 14():607. PubMed ID: 25425433
[TBL] [Abstract][Full Text] [Related]
18. Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia.
Roghmann MC; McCarter RJ; Brewrink J; Cross AS; Morris JG
Clin Infect Dis; 1997 Nov; 25(5):1056-9. PubMed ID: 9402356
[TBL] [Abstract][Full Text] [Related]
19. Impact of piperacillin-tazobactam shortage on meropenem use: implications for antimicrobial stewardship programs.
Barber KE; Bell AM; Travis King S; Parham JJ; Stover KR
Braz J Infect Dis; 2016; 20(6):631-634. PubMed ID: 27609214
[TBL] [Abstract][Full Text] [Related]
20. [Piperacillin/Tazobactam Shortage: Central Restriction and Alternative Recommendations as Effective Antibiotic-Stewardship Intervention at a Maximal Care Hospital].
Kessel J; Dolff B; Wichelhaus T; Keiner N; Hogardt M; Reinheimer C; Wieters I; Harder S; Kempf VAJ; Stephan C;
Dtsch Med Wochenschr; 2018 Apr; 143(8):e59-e67. PubMed ID: 29237206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
